Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06846814

Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions Characterization

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Graziella di Grezia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigates the utility of second-look ultrasound (US) following contrast-enhanced mammography (CEM) to characterize additional lesions detected during routine breast imaging.

Detailed description

The goal is to assess the diagnostic accuracy and clinical value of combining CEM with targeted ultrasound to improve lesion characterization and guide biopsy decisions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCEM protocolThe intervention consists of Second-Look Ultrasound (SLUS) performed following Contrast-Enhanced Mammography (CEM) to further evaluate additional lesions detected during routine breast imaging. When CEM identifies additional or suspicious lesions not clearly characterized by mammography alone, targeted ultrasound is conducted to assess lesion morphology, vascularity, and acoustic characteristics. Radiologists with expertise in both CEM and ultrasound interpretation will perform SLUS to determine whether the lesions require biopsy, short-term follow-up, or no further action. Findings will be correlated with histopathological results (if biopsy is performed) or follow-up imaging to assess diagnostic accuracy.

Timeline

Start date
2025-01-01
Primary completion
2025-12-31
Completion
2026-01-31
First posted
2025-02-26
Last updated
2025-02-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06846814. Inclusion in this directory is not an endorsement.